Orion Engineered Carbons SA (OEC) EPS Estimated At $0.43; Veritas Asset Management Llp Has Cut China Biologic Products (CBPO) Position

October 12, 2017 - By Darrin Black

Analysts expect Orion Engineered Carbons SA (NYSE:OEC) to report $0.43 EPS on November, 2.They anticipate $0.06 EPS change or 16.22% from last quarter’s $0.37 EPS. OEC’s profit would be $25.64 million giving it 13.75 P/E if the $0.43 EPS is correct. After having $0.41 EPS previously, Orion Engineered Carbons SA’s analysts see 4.88% EPS growth. About 98,892 shares traded. Orion Engineered Carbons SA (NYSE:OEC) has risen 24.57% since October 12, 2016 and is uptrending. It has outperformed by 7.87% the S&P500.

Veritas Asset Management Llp decreased China Biologic Products Inc (CBPO) stake by 25% reported in 2017Q2 SEC filing. Veritas Asset Management Llp sold 5,000 shares as China Biologic Products Inc (CBPO)’s stock rose 0.78%. The Veritas Asset Management Llp holds 15,000 shares with $1.70 million value, down from 20,000 last quarter. China Biologic Products Inc now has $2.65 billion valuation. The stock declined 14.20% or $13.8 reaching $83.35 per share. About 1.22 million shares traded or 382.87% up from the average. China Biologic Products Holdings, Inc. (NASDAQ:CBPO) has declined 1.48% since October 12, 2016 and is downtrending. It has underperformed by 18.18% the S&P500.

Veritas Asset Management Llp increased Baxter International Inc (NYSE:BAX) stake by 227,343 shares to 10.18M valued at $616.24 million in 2017Q2. It also upped Express Scripts Holding Co (NASDAQ:ESRX) stake by 952,249 shares and now owns 8.19M shares. Comcast Corp New (NASDAQ:CMCSA) was raised too.

Since May 8, 2017, it had 0 insider buys, and 1 sale for $873,638 activity. Liu Zhijing CBPO had sold 7,500 shares worth $873,638.

Analysts await China Biologic Products Holdings, Inc. (NASDAQ:CBPO) to report earnings on November, 1. They expect $1.30 earnings per share, up 28.71% or $0.29 from last year’s $1.01 per share. CBPO’s profit will be $41.33M for 16.03 P/E if the $1.30 EPS becomes a reality. After $1.35 actual earnings per share reported by China Biologic Products Holdings, Inc. for the previous quarter, Wall Street now forecasts -3.70% negative EPS growth.

Among 2 analysts covering China Biologic Products (NASDAQ:CBPO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. China Biologic Products had 5 analyst reports since September 4, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Friday, September 4 with “Buy”. The firm earned “Buy” rating on Monday, June 12 by Jefferies. The rating was maintained by Jefferies with “Buy” on Tuesday, September 12. The company was maintained on Thursday, August 3 by Jefferies.

Investors sentiment decreased to 0.65 in 2017 Q2. Its down 0.37, from 1.02 in 2017Q1. It fall, as 27 investors sold CBPO shares while 42 reduced holdings. 11 funds opened positions while 34 raised stakes. 15.29 million shares or 21.23% less from 19.41 million shares in 2017Q1 were reported. Bnp Paribas Arbitrage Sa has 0% invested in China Biologic Products Holdings, Inc. (NASDAQ:CBPO) for 10 shares. Northern Tru stated it has 0% in China Biologic Products Holdings, Inc. (NASDAQ:CBPO). Altrinsic Global Advsrs Limited Liability, Connecticut-based fund reported 41,858 shares. Public Employees Retirement Sys Of Ohio has 14,791 shares. Millennium Mgmt Ltd reported 4,334 shares. Icon Advisers has 0.12% invested in China Biologic Products Holdings, Inc. (NASDAQ:CBPO). Renaissance Technology Limited Liability Company holds 0.01% in China Biologic Products Holdings, Inc. (NASDAQ:CBPO) or 82,100 shares. Comgest Investors Sas holds 151,603 shares. Savings Bank Of Mellon has 0.02% invested in China Biologic Products Holdings, Inc. (NASDAQ:CBPO) for 586,459 shares. Axa reported 0.05% of its portfolio in China Biologic Products Holdings, Inc. (NASDAQ:CBPO). Ahl Prns Ltd Liability Partnership accumulated 7,445 shares. Blackrock invested in 1.42 million shares or 0.01% of the stock. Sg Americas Securities Ltd stated it has 0.02% in China Biologic Products Holdings, Inc. (NASDAQ:CBPO). Manning Napier Advisors Limited Liability Company holds 71,755 shares. York Capital Mngmt Glob Lc holds 80,229 shares or 0.19% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>